| Dr Li Liang, MD | |
|
9 Village Sq, Chelmsford, MA 01824-2712 | |
| (978) 256-4531 | |
| (978) 256-1377 |
| Full Name | Dr Li Liang |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 42 Years |
| Location | 9 Village Sq, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912994567 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 214164 (Massachusetts) | Primary |
| 207KA0200X | Allergy & Immunology - Allergy | 11815 (New Hampshire) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Specialists, Pc | 3577508670 | 5 |
| Allergy And Asthma Specialists, Pc | 3577508670 | 5 |
News Archive
New research in the US has found that a mutation in a single gene causes a form of chronic kidney disease.
Chelsea Therapeutics International, Ltd. reported financial results for the fourth quarter and full year 2009 and will host a conference call this afternoon at 4:30 PM ET to discuss these results and provide a quarterly update on the Company's development progress.
Dendrimer nanoparticles, made of spherical, highly branched polymers, have shown promise as drug delivery vehicles capable of targeting tumors with large doses of anticancer drugs.
Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.
› Verified 3 days ago
| Entity Name | Allergy & Asthma Specialists, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306837968 PECOS PAC ID: 3577508670 Enrollment ID: O20050620000892 |
News Archive
New research in the US has found that a mutation in a single gene causes a form of chronic kidney disease.
Chelsea Therapeutics International, Ltd. reported financial results for the fourth quarter and full year 2009 and will host a conference call this afternoon at 4:30 PM ET to discuss these results and provide a quarterly update on the Company's development progress.
Dendrimer nanoparticles, made of spherical, highly branched polymers, have shown promise as drug delivery vehicles capable of targeting tumors with large doses of anticancer drugs.
Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Li Liang, MD 9 Village Sq, Chelmsford, MA 01824-2712 Ph: (978) 256-4531 | Dr Li Liang, MD 9 Village Sq, Chelmsford, MA 01824-2712 Ph: (978) 256-4531 |
News Archive
New research in the US has found that a mutation in a single gene causes a form of chronic kidney disease.
Chelsea Therapeutics International, Ltd. reported financial results for the fourth quarter and full year 2009 and will host a conference call this afternoon at 4:30 PM ET to discuss these results and provide a quarterly update on the Company's development progress.
Dendrimer nanoparticles, made of spherical, highly branched polymers, have shown promise as drug delivery vehicles capable of targeting tumors with large doses of anticancer drugs.
Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.
› Verified 3 days ago
Elizabeth Yakaboski, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9 Village Sq, Chelmsford, MA 01824 Phone: 978-256-4531 | |
Dr. David A Gruenberg, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9 Village Sq, Chelmsford, MA 01824 Phone: 978-256-4531 Fax: 978-256-1377 | |
Dr. Julia Lynn Montejo, M.D. Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 9 Village Sq, Chelmsford, MA 01824 Phone: 978-256-4531 Fax: 978-256-1377 | |
Dr. Wilfred N. Beaucher, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9 Village Sq, Chelmsford, MA 01824 Phone: 978-256-4531 Fax: 978-256-1377 |